![Andreas Moraitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Moraitis
Hoofd Techniek/Wetenschap/O&O bij
MBX BIOSCIENCES, INC.
Profiel
Dr. Andreas Moraitis, MD, is a Senior Vice President-Clinical Development at MBX Biosciences, Inc. Dr. Moraitis was previously employed as a Head-Clinical Development by Corcept Therapeutics, Inc. He received his doctorate degree from National & Kapodistrian University of Athens.
Actieve functies van Andreas Moraitis
| Bedrijven | Functie | Begin |
|---|---|---|
| MBX BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 23-06-2025 |
Eerdere bekende functies van Andreas Moraitis
| Bedrijven | Functie | Einde |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Corporate Officer/Principal | - |
Opleiding van Andreas Moraitis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Kies MarketScreener 
